HIGHLIGHTS
- who: Haosheng Zheng and collaborators from the DepartmentUniversity, Guangzhou, China have published the article: Correction: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. Cancers 2022, 14,, in the Journal: Cancers 2023, 15, 586. of 10/01/2023
SUMMARY
Received Published: 18 January 2023 2 of 2 The authors would like to apologize for any inconvenience caused. Zheng, H.; Long, G.; Zheng, Y.; Yang, X.; Cai, W.; He, S.; Qin, X.; Liao, H. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.